Development and Validation of a Model to Predict Fast Progression in Glaucoma
clinical trial
Press Enter · cited answer in seconds
0 sources
Summary
Development and Validation of a Model to Predict Fast Progression in Glaucoma is a clinical trial[1].
Key Facts
- Development and Validation of a Model to Predict Fast Progression in Glaucoma is in the country of United States[2].
- Development and Validation of a Model to Predict Fast Progression in Glaucoma's instance of is recorded as clinical trial[3].
- Development and Validation of a Model to Predict Fast Progression in Glaucoma's start time is recorded as +2020-08-31T00:00:00Z[4].
- Development and Validation of a Model to Predict Fast Progression in Glaucoma's end time is recorded as +2025-08-31T00:00:00Z[5].
- Development and Validation of a Model to Predict Fast Progression in Glaucoma's contributor to the creative work or subject is recorded as Genentech[6].
- Development and Validation of a Model to Predict Fast Progression in Glaucoma's sponsor is recorded as Duke University[7].
- Development and Validation of a Model to Predict Fast Progression in Glaucoma's main subject is recorded as glaucoma[8].
- Development and Validation of a Model to Predict Fast Progression in Glaucoma's main subject is recorded as ocular hypertension[9].
- Development and Validation of a Model to Predict Fast Progression in Glaucoma's number of participants is recorded as {'unit': '1', 'amount': '+5200'}[10].
- Development and Validation of a Model to Predict Fast Progression in Glaucoma's title is recorded as Development and Validation of a Model to Predict Fast Progression in Glaucoma[11].
- Development and Validation of a Model to Predict Fast Progression in Glaucoma's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+40'}[12].
- Development and Validation of a Model to Predict Fast Progression in Glaucoma's ClinicalTrials.gov ID is recorded as NCT04454190[13].
- Development and Validation of a Model to Predict Fast Progression in Glaucoma's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+90'}[14].
- Development and Validation of a Model to Predict Fast Progression in Glaucoma's research site is recorded as Duke Eye Center[15].
- Development and Validation of a Model to Predict Fast Progression in Glaucoma's research subject recruitment status is recorded as not yet recruiting[16].
- Development and Validation of a Model to Predict Fast Progression in Glaucoma's study type is recorded as observational study[17].